Neuralstem Files Spinal Cord IND Amid Stem Cell Hubbub

Boggs, Jennifer
August 2010
BioWorld Today;8/26/2010, Vol. 21 Issue 165, p1
The article reports that Rockville, Maryland-based Neuralstem Inc. has filed an investigational new drug (IND) application for the clinical trial of the first stem cell therapy for spinal cord injury. The IND application was filed two days after a federal judge ruled against the stem cell policy of President Barack Obama. According to president and chief executive officer (CEO) Richard Garr, the Neuralstem technology is designed to isolate central nervous system (CNS) stem cells from fetal tissues.


Related Articles

  • Spinal Injury Showdown: Stem Cell Race Heats Up. Orelli, Brian // BioWorld Insight;11/22/2010, Vol. 18 Issue 47, p3 

    The article discusses the effectiveness of stem cell therapy developed by StemCells Inc. to treat patients with spinal cord injuries. Based on clinical trials, company's vice president Stephen Huhn stated that the strategic approach would help the patients to recover from additional underlying...

  • New techniques? Yes, but let it be ethical. A warning from ISCoS. Wyndaele, J J // Spinal Cord;Apr2011, Vol. 49 Issue 4, p485 

    In this article the author reflects on the ethics of using stem cell transplants for the treatment of spinal cord injuries (SCI). The author notes that the use of bone marrow-derived (hematopoietic) stem cells have been used to treat some blood-borne and immunological disorders, but is an...

  • First stem cell trial. Coghlan, Andy // New Scientist;10/16/2010, Vol. 208 Issue 2782, p7 

    The article reports a stem-cell trial in which surgeons at the Shepherd Center in Atlanta, Georgia, injected oligodendrocyte progenitor cells grown from human embryonic stem cells (hESCs) into an individual with spinal injuries.

  • Potential role of stem cells in severe spinal cord injury: current perspectives and clinical data. Paspala, Syed A. B.; Vishwakarma, Sandeep K.; Murthy, Tenneti V. R. K.; Rao, Thiriveedi N.; Khan, Aleem A. // Stem Cells & Cloning: Advances & Applications;2012 Part 2, Vol. 5, p15 

    Stem cell transplantation for spinal cord injury (SCI) along with new pharmacotherapy research offers the potential to restore function and ease the associated social and economic burden in the years ahead. Various sources of stem cells have been used in the treatment of SCI, but the most...

  • Clinical and Experimental Advances in Regeneration of Spinal Cord Injury. Jung Keun Hyun; Hae-Won Kim // Journal of Tissue Engineering;2010, p1 

    Spinal cord injury (SCI) is one of the major disabilities dealt with in clinical rehabilitation settings and is multifactorial in that the patients suffer from motor and sensory impairments as well as many other complications throughout their lifetimes.Many clinical trials have been documented...

  • One Door Closes and Another One Opens. Long, Frank // Rehab Management: The Interdisciplinary Journal of Rehabilitatio;Sep2012 Supplement, Vol. 25, p6 

    The author discusses the Miami Project to Cure Paralysis, a Center of Excellence at the University of Miami Miller School of Medicine. He believes that the Miami Project is a hope and change in arena of long-term rehabilitation and spinal cord injury (SCI) since the shutdown of a phase 1...

  • Editor's Message. The Influence of Money, Monkeys, and a President. Long, Frank // Rehab Management: The Interdisciplinary Journal of Rehabilitatio;Jan/Feb2012, Vol. 25 Issue 1, p6 

    The article offers the author's insight on the challenges and developments in the stem cell research using chimera and human subjects in 2011, with regards to the clinical trial held by Geron at the Shepherd Center in Atlanta, Georgia. He discusses the lack of resources and problems of securing...

  • Transplantation of a combination of autologous neural differentiated and undifferentiated mesenchymal stem cells into injured spinal cord of rats. Pedram, M S; Dehghan, M M; Soleimani, M; Sharifi, D; Marjanmehr, S H; Nasiri, Z // Spinal Cord;Jun2010, Vol. 48 Issue 6, p457 

    Study design:The use of stem cells for functional recovery after spinal cord injury.Objective:The aim of this study was to evaluate the effects of a combination of autologous undifferentiated and neural-induced bone marrow mesenchymal stem cells (MSCs) on behavioral improvement in rats after...

  • Potential adverse effects of cyclosporin A on kidneys after spinal cord injury. Lonjon, N; Boniface, G; Feifel, R; Endres, R; Gimenez y Ribotta, M; Privat, A; Perrin, F E // Spinal Cord;Mar2011, Vol. 49 Issue 3, p472 

    Study design:Cell transplantation strategies are gaining increasing interest for spinal cord injury (SCI) with the objective of promoting spinal cord repair. To avoid allogenic graft rejection, an adequate immune suppression is required, and one of the most potent and commonly used...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics